A detailed history of Td Private Client Wealth LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 885 shares of INVA stock, worth $17,700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
885
Holding current value
$17,700
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$14.4 - $16.4 $12,744 - $14,513
885 New
885 $14.5 Million
Q1 2024

Aug 16, 2024

SELL
$14.56 - $16.78 $480 - $553
-33 Reduced 7.69%
396 $6.04 Million
Q3 2023

Aug 16, 2024

SELL
$12.37 - $13.89 $3,995 - $4,486
-323 Reduced 42.95%
429 $5.57 Million
Q3 2022

Aug 16, 2024

BUY
$11.61 - $15.22 $3,459 - $4,535
298 Added 65.64%
752 $8.73 Million
Q1 2022

Aug 16, 2024

SELL
$15.39 - $20.25 $6,633 - $8,727
-431 Reduced 48.7%
454 $8.79 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.39B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.